Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Condition: Pancreatic Cancer Intervention: Radiation: Daily Adaptive External Beam Radiation Therapy Sponsors: Varian, a Siemens Healthineers Company; Washington University School of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | External Beam Therapy | Pancreas | Pancreatic Cancer | Radiation Therapy | Research